ERBB2 and breast cancer: In conclusion, these results warrant further studies in animal models with the aim to evaluate the effectiveness of the combinatorial treatment of Tz with putative pharmacological inhibitors of CHD4 in the inhibition of ERBB2+ BC development and/or progression.